Use Of Statin Drugs (Lipitor) Has Been Linked To An Increased Risk Of Diabetes
A study in the Archive of Internal Medicine by the Women’s Health Initiative concluded that statin medication in post menopausal women is linked to an increased risk of developing diabetes.
If you or a loved one are post-menopausal woman who took Lipitor and developed diabetes while taking Lipitor, you may have a claim against the manufacturer.
In a the Archive of Internal Medicine Study, the Women’s Health Initiative looked at over 150,000 women between 50 to 79 years old to see if there was an association between the use of statins and developing diabetes mellitus (DM). The study concluded:
“Statin medication in post menopausal women is associated with an increased risk of DM”.
The study also reported a significantly increased risk of DM with women with a BMI below 30 as compared to women above 30. Other studies have also confirmed an association between statins and diabetes.
What About Lipitor?
Lipitor is a popular statin medication designed to lower cholesterol levels by adjusting body enzyme levels. We have heard of the “good” cholesterol (HDL) and the “bad” cholesterol (LDL). Lipitor is taken to lower LDLs and reduce the risk of blocked arteries. Lipitor is sold by Pfizer and was approved by the FDA in 1996 and is meant to be taken daily. Since its introduction, Liptor has produced over $126 billion in sales.
In February 2012, the FDA announced it was requiring new diabetes warnings for Lipitor. The Brandi Law Firm is nationally recognized for its decades of involvement in lawsuits over defective drugs and is investigating Lipitor lawsuits for a number of women, including linking into BMI and statin diabetes risks and other studies linking use of statin to increased risk of diabetes.